> Cardium Therapeutics has raised $30 million in private financing and is planning to acquire a portfolio of cardiovascular therapies from Schering as it goes public by merging into a shell company. Release
> Chutes & Ladders: PDI announced that CEO Charles T. Saldarini has resigned and that executive vice president Larry Ellberger was chosen as interim CEO until a permanent replacement was found. No reason for the resignation was given. Report
> SkinMedica has become the latest victim of "market conditions," pulling its IPO originally filed last April. Report
> Zelos Therapeutics is moving its small HQ from Waltham, MA, to Philadelphia. Report
And Finally... Acting New Jersey Gov. Richard Codey has announced new measures to support stem cell research in the state. Article